Autolus Therapeutics (AUTL)

• Market cap: $413M
• 1 day: -1.27%
• 5 days: 10.71%
• 1 month: 11.51%
• 3 months: 6.16%
• 6 months: -31.42%
• Year to date: -41.06%
• 1 year: -46.92%
• 5 years: -87.03%
• 10 years: -93.8%
• Sector: Healthcare
• Industry: Biotechnology

About: Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Employees: 647